15 research outputs found
An approach for the identification of targets specific to bone metastasis using cancer genes interactome and gene ontology analysis
Metastasis is one of the most enigmatic aspects of cancer pathogenesis and is
a major cause of cancer-associated mortality. Secondary bone cancer (SBC) is a
complex disease caused by metastasis of tumor cells from their primary site and
is characterized by intricate interplay of molecular interactions.
Identification of targets for multifactorial diseases such as SBC, the most
frequent complication of breast and prostate cancers, is a challenge. Towards
achieving our aim of identification of targets specific to SBC, we constructed
a 'Cancer Genes Network', a representative protein interactome of cancer genes.
Using graph theoretical methods, we obtained a set of key genes that are
relevant for generic mechanisms of cancers and have a role in biological
essentiality. We also compiled a curated dataset of 391 SBC genes from
published literature which serves as a basis of ontological correlates of
secondary bone cancer. Building on these results, we implement a strategy based
on generic cancer genes, SBC genes and gene ontology enrichment method, to
obtain a set of targets that are specific to bone metastasis. Through this
study, we present an approach for probing one of the major complications in
cancers, namely, metastasis. The results on genes that play generic roles in
cancer phenotype, obtained by network analysis of 'Cancer Genes Network', have
broader implications in understanding the role of molecular regulators in
mechanisms of cancers. Specifically, our study provides a set of potential
targets that are of ontological and regulatory relevance to secondary bone
cancer.Comment: 54 pages (19 pages main text; 11 Figures; 26 pages of supplementary
information). Revised after critical reviews. Accepted for Publication in
PLoS ON
An Approach for the Identification of Targets Specific to Bone Metastasis Using Cancer Genes Interactome and Gene Ontology Analysis
Metastasis is one of the most enigmatic aspects of cancer pathogenesis and is a major cause of cancer-associated mortality.
Secondary bone cancer (SBC) is a complex disease caused by metastasis of tumor cells from their primary site and is
characterized by intricate interplay of molecular interactions. Identification of targets for multifactorial diseases such as SBC,
the most frequent complication of breast and prostate cancers, is a challenge. Towards achieving our aim of identification of
targets specific to SBC, we constructed a âCancer Genes Networkâ, a representative protein interactome of cancer genes.
Using graph theoretical methods, we obtained a set of key genes that are relevant for generic mechanisms of cancers and
have a role in biological essentiality. We also compiled a curated dataset of 391 SBC genes from published literature which
serves as a basis of ontological correlates of secondary bone cancer. Building on these results, we implement a strategy
based on generic cancer genes, SBC genes and gene ontology enrichment method, to obtain a set of targets that are
specific to bone metastasis. Through this study, we present an approach for probing one of the major complications in
cancers, namely, metastasis. The results on genes that play generic roles in cancer phenotype, obtained by network analysis
of âCancer Genes Networkâ, have broader implications in understanding the role of molecular regulators in mechanisms of
cancers. Specifically, our study provides a set of potential targets that are of ontological and regulatory relevance to
secondary bone cancer
The percentage of essential genes in the hubs and the corresponding non-hubs of CGN.
<p>A. For hub definitions varying between Top25 to Top200, the hubs identified using degree (1, âredâ), betweenness (2, âgreenâ), and stress (3, âblueâ) have significantly high percentage (82%â92%) of essential genes, classified using phenotypic data for Mouse Genome Informatics. Among the rest of the four parameters neighborhood connectivity (4) and topological coefficient (5) show neither significant nor consistent correlation with essential genes. Due to the nature of âclustering coefficientâ and âaverage shortest path lengthâ parameters, the data could not be binned at the same intervals. For clustering coefficient, percentage of essential genes among the nodes having up to Top200 rankings is in the range of 27% and 62%. For average shortest path length, the percentage of essential genes for nodes having ranking up to Top200 is 26%, worse than expected from random sampling. B. In the corresponding non-hubs, the percentage of essential genes is as expected from random sampling, regardless of the centrality measure or cut-off used for hub definition.</p
Venn diagrams depicting the strategy used for the identification of SBC-specific targets.
<p>A. Venn diagram legend representing generic cancer genes identified by network analysis (CGN hub genes; gray area) and gene subsets used as a source of target genes that are specific to bone metastasis (hatched area). In search of SBC-specific targets, the generic cancer genes were rejected and the potential source of target genes was refined to obtain the final targets. B. Venn diagram depicting components of gene-sets identified using Top75 hubs. The source set of target genes (53+134) was refined to obtain seven targets.</p
Heatmap of topological metrics computed for Cancer Genes Network.
<p>The heatmap of pair-wise correlations among seven parameters that enumerate topological, dynamical and local clustering features of the network: betweenness, stress, degree, neighborhood connectivity (neigh_conn), clustering coefficient (clust_coeff), average shortest path length (avg_short_paths) and topological coefficient (topo_coeff). The heatmap highlights three parameters with very high mutual positive correlations (râ=â0.8989, 0.9930 and 0.9210): degree, betweenness and stress. The upper triangle of the heatmap depicts pair-wise correlations as pie charts. The lower triangle depicts positive and negative correlations in shades of blue and red, respectively; the darker the color the stronger the correlation. Positive and negative correlations are also depicted with right- and left-handed diagonal lines.</p
CGN, a representative protein interactome of cancer genes, Top75 hub genes and SBC-specific targets.
<p>Cancer Genes Network (CGN) is a protein interactome of cancer genes embodying molecular mechanisms of cancers. Each node represents a cancer protein and an edge between two nodes represents a protein-protein interaction. The giant cluster comprises 89% of all cancer genes. The hubs of CGN, cancer genes central to the structural stability and information dynamics, are depicted in shades of red. The hubs encode genes involved in generic cancer mechanisms and those classified as essential using phenotypic data from Mouse Genome Informatics. 88% of these hubs are essential (âdark redâ) and the rest non-essential (âlight redâ). SBC-specific targets, with ontological role in bone and metastasis processes, are highlighted in âgreenâ.</p
Overrepresented GO terms of processes relevant and necessary for execution of bone metastasis.
<p>From the GO enrichment studies of SBCGs, curated from literature, 21 GO terms relevant for metastasis (âlight grayâ) and 10 GO terms relevant for bone (âdark grayâ) processes were identified.</p
Hubs of CGN correlate with generic cancer genes (KEGG-PIC).
<p>The hubs of CGN, identified using chosen network centrality parameters, correlate with the set of generic cancer genes (KEGG-PIC). For hub definitions varying between Top25âTop200, the CGN hubs (top ranked cancer genes) show good overlap with KEGG-PIC genes (filled circles). The correspondence of network centrality and generic role in cancers, expectedly, drops as the strictness of criterion used for identifying hubs is loosened. For the corresponding random samples, the overlap with KEGG-PIC is as expected (stars; error bars indicate standard errors from 1000 samples). The cancer genes with worst centrality rankings (open circles), show almost no overlap with generic cancer genes; worse than that expected from random samplings. Top75, Top50 and Top25 hubs, with 52%, 57% and 74% overlap with generic cancer genes, respectively, were further used for identification of SBC-specific cancer genes.</p
Venn diagram of gene sets obtained with Top25 and Top50 CGN hubs.
<p>The Venn diagrams with generic gene-set (gray area) and source set of target genes (hatched area) for (A) Top25 and (B) Top50 CGN hubs.</p
Regulatory mechanisms underlying metastasis to bone reflecting complex interplay of molecules.
<p>Bone metastasis results from imbalance of normal bone remodeling process involving osteolytic (leading to bone destruction) and osteoblastic (leading to aberrant bone formation) mechanisms. Breast cancer metastases are usually osteolytic, whereas prostate cancer metastases are usually osteoblastic. <b>Osteolytic metastasis</b>: Osteolytic metastasis of tumor cells involves a âvicious cycleâ between tumor cells and the skeleton. The vicious cycle is propagated by four contributors: tumor cells, bone-forming osteoblasts, bone resorbing osteoclasts and stored factors within bone matrix. Osteoclast formation and activity are regulated by the osteoblast, adding complexity to the vicious cycle. Tumor cells release certain factors including IL-1, IL-6, IL-8, IL-11, PTHrP and TNF that stimulate osteoclastic bone resorption. These factors enhance the expression of RANKL over OPG by osteoblasts, tipping the balance toward osteoclast activation thus causing bone resorption. This bone lysis stimulates the release of BMPs, TGFβ, IGFs and FGFs for stimulating the growth of metastatic cancer cells to bone. <b>Osteoblastic metastasis:</b> Factors released by osetoblastic cells, such as ET-1, Wnt, ERBB3, VEGF play an important role in osteoblastic metastasis by increasing cancer cell proliferation and enhance the effect of other growth factors including PDGF, FGFs, IGF-1. Osteoblast differentiation is also increased by BMPs through the activation of certain transcription factors. Urokinase Plasminogen Activator (uPA), a protease, also acts as mediator for osteoblastic bone metastasis by cleaving osteoclast-mediated bone resorption factors responsible for regulation of osteoclast differentiation; thereby blocking the bone resorption.</p